Ospedale Giovan Battista Morgagni-Luigi Pierantoni Di Forlì — Clinical Trial Site

11 Registered trials

5 Currently recruiting

Organisation

Ospedale Giovan Battista Morgagni-Luigi Pierantoni Di Forlì

Location

Forli', Italy

Identifier

ORG-100023584

Address

Via Carlo Forlanini 34, 47121, Italy

Departments

Cardiology
Department of specialistic medicine -Pneumology Unit
Department of Specialized Medicines
Dipartimento Emergenza, Internistico e Cardiologico Forlì e Cesena-U.O.C. di Cardiologia
Dipartimento Toracico - AUSL di Forlì
Medicina Specialistica – UO Pneumologia
Pneumologia Interventistica
Pneumology Unit
S.C. Pneumologia
U.O. Pneumologia

Clinical trials at this site (11)

Search interface

A seamless, phase 1b/2 multiple ascending dose/proof of concept study of XTMAB-16 in patients with pulmonary sarcoidosis with or without ext… Not authorised

2022-502877-41-00 Pulmonary sarcoidosis with or without extrapulmonary ma 9
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis Recruiting

2023-503699-25-00 Progressive Pulmonary Fibrosis 5 2024-07-15
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis Recruiting

2023-503697-21-01 Idiopathic pulmonary fibrosis 5 2024-06-24
A seamless, phase 1b/2 multiple ascending dose/proof of concept study of XTMAB-16 in patients with pulmonary sarcoidosis with or without ext… Recruiting

2022-502877-41-01 Pulmonary sarcoidosis with or without extrapulmonary ma 9 2025-02-10
A follow-up study to test long-term treatment with BI 1015550 in people with pulmonary fibrosis who took part in a previous study with BI 10… Recruiting

2023-507353-15-00 idiopathic pulmonary fibrosis (IPF) 5 2024-09-10
WOEST-3 Recruiting

2022-502140-13-00 Atrial fibrillation Acute coronary syndrome Chronic cor 6 2023-01-11
A study to determine if ALXN2220 is effective, safe, and tolerable in adults with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Ended

2023-506669-70-00 Adults with Transthyretin Amyloid Cardiomyopathy (ATTR- 5 2024-04-30
Extension Study of Inhaled Treprostinil in Subjects with Fibrotic Lung Disease Ended

2023-504471-25-00 Fibrotic Lung Disease 5 2024-03-01
A Phase 1/2a Study Evaluating the Effects of ARO-MMP7 Inhalation Solution in Healthy Subjects and Patients with Idiopathic Pulmonary Fibrosi… Ended

2023-504964-41-00 Idiopathic pulmonary fibrosis 7 2024-11-06
A Study to Evaluate the Efficacy and Safety of Vixarelimab Compared with Placebo in Patients with Idiopathic Pulmonary Fibrosis and in Patie… Ended

2022-502828-42-00 Idiopathic Pulmonary Fibrosis 4 2023-09-01
A Phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous efzofitimod in patients wit… Ended

2023-506039-13-00 pulmonary sarcoidosis 5 2023-04-12